Several mechanisms could explain the benefit of RAAS inhibitors on MR in HF, including reverse LV remodelling, afterload reduction and beneficial effects on valve leaflet remodelling [46, 47]. This evidence concerns the gene NR3C2 and hydrops fetalis.